Publicacións nas que colabora con Jaime Feliu Batlle (12)

2024

  1. Update on the management of older patients with pancreatic adenocarcinoma: a perspective from medical oncology

    Clinical and Translational Oncology

2023

  1. Utility of CYP2D6 copy number variants as prognostic biomarker in localized anal squamous cell carcinoma

    Cancer, Vol. 129, Núm. 16, pp. 2581-2592

2021

  1. Phase II clinical trial of nab-paclitaxel plus gemcitabine in elderly patients with previously untreated locally advanced or metastatic pancreatic adenocarcinoma: the BIBABRAX study

    Cancer Chemotherapy and Pharmacology, Vol. 87, Núm. 4, pp. 543-553

  2. SEOM clinical guidelines for pancreatic and biliary tract cancer (2020)

    Clinical and Translational Oncology, Vol. 23, Núm. 5, pp. 988-1000

2019

  1. Tumor-associated macrophage-secreted 14-3-3ζ signals via AXL to promote pancreatic cancer chemoresistance

    Oncogene, Vol. 38, Núm. 27, pp. 5469-5485

2016

  1. SEOM Clinical Guideline for the treatment of pancreatic cancer (2016)

    Clinical and Translational Oncology, Vol. 18, Núm. 12, pp. 1172-1178

2015

  1. Clinical guideline SEOM: hepatocellular carcinoma

    Clinical and Translational Oncology, Vol. 17, Núm. 12, pp. 988-995

2010

  1. Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer

    British Journal of Cancer, Vol. 102, Núm. 10, pp. 1468-1473

2009

  1. Combination therapy with docetaxel and low dose of cisplatin in elderly patients with advanced non-small cell lung cancer: Multicenter phase II study

    Cancer Chemotherapy and Pharmacology, Vol. 63, Núm. 3, pp. 403-409

2005

  1. Capecitabine as first-line treatment for patients older than 70 years with metastatic colorectal cancer: An Oncopaz Cooperative Group Study

    Journal of Clinical Oncology, Vol. 23, Núm. 13, pp. 3104-3111

2004

  1. Phase II study of UFT and oxaliplatin in first-line treatment of advanced colorectal cancer

    British Journal of Cancer, Vol. 91, Núm. 10, pp. 1758-1762

2002

  1. Phase II study of a fixed dose-rate infusion of gemcitabine associated with uracil/tegafur in advance carcinoma of the pancreas

    Annals of Oncology, Vol. 13, Núm. 11, pp. 1756-1762